D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1751
PayPay
PAYP
$9.92B
| $7.68M | ﹤0.01% |
+360,000
| New | +$7.62M |
2026 Q1
0 quarters
|
|
1752
CALL
DELISTED
Warner Bros
WBD
| $7.67M | ﹤0.01% |
279,300
-2,414,500
| -90% | -$67.6M |
2021 Q1
20 quarters
|
|
1753
PUT
APA Corp
APA
$16.5B
| $7.67M | ﹤0.01% |
180,700
-901,500
| -83% | -$27.3M |
2021 Q1
20 quarters
|
|
|
CEPT
1754
DELISTED
Cantor Equity Partners II
CEPT
| $7.67M | ﹤0.01% |
704,187
| – | – |
2025 Q2
3 quarters
|
|
1755
Fox Class A
FOXA
$27B
| $7.66M | ﹤0.01% |
131,225
-673,173
| -84% | -$42.9M |
2021 Q1
20 quarters
|
|
1756
CALL
Nu Holdings
NU
$71.2B
| $7.66M | ﹤0.01% |
533,200
-2,116,900
| -80% | -$34.3M |
2023 Q2
11 quarters
|
|
1757
CubeSmart
CUBE
$8.68B
| $7.64M | ﹤0.01% |
208,534
-107,669
| -34% | -$4.13M |
2025 Q4
1 quarter
|
|
1758
Hershey
HSY
$33.9B
| $7.59M | ﹤0.01% |
36,523
+33,811
| +1,247% | +$7.13M |
2025 Q4
1 quarter
|
|
1759
Smithfield Foods
SFD
$7.28B
| $7.59M | ﹤0.01% |
271,356
-145,736
| -35% | -$3.5M |
2025 Q4
1 quarter
|
|
1760
Enliven Therapeutics
ELVN
$2.88B
| $7.59M | ﹤0.01% |
+193,531
| New | +$5.36M |
2026 Q1
0 quarters
|
|
1761
Yorkville Acquisition Corp
MCGA
$245M
| $7.58M | ﹤0.01% |
750,000
+650,000
| +650% | +$6.59M |
2025 Q3
2 quarters
|
|
1762
CVR Energy
CVI
$6.2B
| $7.58M | ﹤0.01% |
225,296
-93,227
| -29% | -$2.4M |
2024 Q1
8 quarters
|
|
1763
EGH Acquisition Corp
EGHA
$214M
| $7.58M | ﹤0.01% |
742,500
| – | – |
2025 Q3
2 quarters
|
|
1764
Skyward Specialty Insurance
SKWD
$2.67B
| $7.58M | ﹤0.01% |
173,455
-20,941
| -11% | -$951K |
2023 Q3
10 quarters
|
|
1765
World Kinect Corp
WKC
$1.88B
| $7.57M | ﹤0.01% |
328,234
-15,882
| -5% | -$403K |
2014 Q4
45 quarters
|
|
1766
CALL
USA Rare Earth Inc
USAR
$4.16B
| $7.57M | ﹤0.01% |
+500,000
| New | +$9.7M |
2026 Q1
0 quarters
|
|
1767
GigCapital8
GIW
$372M
| $7.57M | ﹤0.01% |
759,000
| – | – |
2025 Q4
1 quarter
|
|
1768
CALL
American Express
AXP
$212B
| $7.56M | ﹤0.01% |
25,000
-14,100
| -36% | -$4.73M |
2013 Q2
51 quarters
|
|
1769
Accendra Health
ACH
$20.1M
| $7.55M | ﹤0.01% |
3,311,601
-247,004
| -7% | -$569K |
2015 Q4
41 quarters
|
|
|
1770
CALL
Boston Scientific
BSX
$64B
| $7.53M | ﹤0.01% |
+120,000
| New | +$9.6M |
2026 Q1
0 quarters
|
|
1771
ManpowerGroup
MAN
$2.03B
| $7.53M | ﹤0.01% |
255,433
+100,223
| +65% | +$2.98M |
2018 Q2
31 quarters
|
|
1772
DELISTED
Apellis Pharmaceuticals
APLS
| $7.52M | ﹤0.01% |
186,853
-262,823
| -58% | -$5.66M |
2025 Q2
3 quarters
|
|
1773
OneIM Acquisition Corp
OIM
$366M
| $7.51M | ﹤0.01% |
+750,000
| New | +$7.51M |
2026 Q1
0 quarters
|
|
1774
Fox Class B
FOX
$24.1B
| $7.51M | ﹤0.01% |
141,380
-321,368
| -69% | -$18.6M |
2019 Q3
26 quarters
|
|
1775
FIGX Capital Acquisition Corp
FIGX
$201M
| $7.5M | ﹤0.01% |
740,851
| – | – |
2025 Q3
2 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.